本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

142.76
-0.6400-0.45%
成交量:8.07萬
成交額:1,165.78萬
市值:92.38億
市盈率:138.60
高:146.19
開:144.19
低:142.48
收:143.40
52周最高:160.81
52周最低:57.90
股本:6,470.83萬
流通股本:6,316.60萬
量比:0.47
換手率:0.13%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:10.98
市盈率(LYR):-69.64

資料載入中...

2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/02

重要事件披露

8-K/A [Amend] - Current report
2020/09/11

重要事件披露

8-K - Current report
2020/08/13

重要事件披露

8-K - Current report
2020/08/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/06/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/29

重要事件披露

8-K - Current report
2020/05/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/12

重要事件披露

8-K - Current report
2020/05/07

重要事件披露

8-K - Current report